In this insightful episode of Driving Digital in Biopharma, host Tom Lehmann explores with Áine Hanly, Chief Technology Officer at Vir Biotechnology, the transformative role of data and technology in drug development and manufacturing. Áine delves into the advancements in data accessibility and automation, such as single-cell manipulation and high throughput processes, which have notably shortened cycle times and boosted efficiency. She also discusses the innovative use of the Vir AI tool...

This episode of Driving Digital in Biopharma offers a peek into the digital revolution brewing in the biopharma labs, courtesy of Richard Milne, the Vice-president and general manager of Digital Science Solutions at Thermo Fisher Scientific. From e-commerce roots to pioneering digital science, Richard and Tom delve into the vision for laboratories, and the integration of artificial intelligence and automation in scientific research and lab operations. Their conversation highlights the...

In this episode of "Driving Digital in Biopharma," host Tom Lehmann welcomes Morrey Atkinson, the Chief Technology and Operations Officer at Vertex Pharmaceuticals. With a rich background in process development and manufacturing within the pharmaceutical industry, Morrey shares his insights on Vertex's strategic evolution and its commitment to serial innovation through substantial investments in R&D. They discuss the company’s modality-agnostic approach, which allows flexibility in...

In this episode of the Driving Digital in Biopharma podcast, Samer Ansari, Head of Data, Digital, and Technology at Takeda Oncology, joins Tom Lehmann, Global Head of Accenture Life Sciences R&D, to discuss the role of digital in creating exceptional HCP and patient experiences. Through their shared passion for data and tech and the importance of using it to positively change not only the Life Sciences industry but also the lives of our loved ones, Samer and Tom explore how Takeda is...

In this episode of Driving Digital in Biopharma, Accenture host, Tom Lehmann, speaks to Chris Braithwaite, Global Head of Drug Development, Digital and IT Novartis. Achieving digital transformation requires a delicate balance between traditional methods, rapidly emerging technology, and human decision-making. Chris encourages a shift in perspective and a focus on change management, emphasizing that working in a human+machine mode does not entail eliminating human roles. Instead, it involves...

In this episode of Driving Digital in Biopharma, Accenture host, Tom Lehmann, talks with Michel Rider, VP Digital, Analytics and Performance at GSK. Michel reflects on their multi-year quest to modernize digital, data, and analytics capabilities across Development – sharing insights for achieving near-term wins while planning for the future. There is a sense of urgency for patients seeking better, faster treatments. And this is a non-linear endeavor – iteration and evolution are a given. A...

In this episode of Driving Digital in Biopharma, host Tom Lehmann talks with Jason Bronfeld, Head of Product Development IT at Bristol-Myers Squibb, about the industry re-perceiving itself and capitalizing on the power of digital.  When it comes to evolving ways of operating to an ever-better model for the future, a mindset shift is essential – digital is a means and not the end. The biopharma industry is viewed as knowledge-generating enterprises, and while ever-growing amounts of data...

In this episode, Tom Lehmann talks with Natasha Kelly, a data scientist within Accenture's Applied Intelligence Group who focuses on advanced analytic solutions in life sciences manufacturing and supply chain. Tom and Natasha discuss the 2022 Life Sciences Technology Vision through a supply chain lens, delving into how each of the report's four trends ingrained in the metaverse are reshaping supply chain and operations experiences across the industry.

In this episode, Tom Lehmann talks with Accenture’s Ross Wooddisse, Managing Director and Life Sciences R&D Lead in Europe, about the 2022 Life Sciences Technology Vision and what the Metaverse continuum means for Biopharma R&D. They discuss how science turns into medicine, a new generation of digital trial capabilities and the fundamental opportunity for the industry to move from disease management towards risk prediction and disease prevention.

In this episode Tom Lehmann talks with Shalu Chada, Managing Director and Accenture’s Life Sciences Technology Lead, to discuss the 2022 Life Sciences Technology Vision and how each of the report's four trends ingrained in the metaverse are reshaping biopharma experiences of the future.

In this episode of Driving Digital in Biopharma, host Tom Lehmann talks with Anders Persson – Executive Director, Ecosystem Strategy & Innovation, AstraZeneca, about the role of digital and data in the transformation of global drug development and the value of an ecosystem and partnership strategy in R&D.

Tom and Eddie discuss the goal of delivering new therapies to patients more efficiently and how that’s enabled by regulatory - from standardizing data to more proficiently exchanging data with health authorities. The two discuss how data mining and artificial intelligence are being applied to that work.

Host Tom Lehmann talks with Lars Fogh Iversen, Senior Vice Present for Digital Science & Innovation at Novo Nordisk. They discuss the journey to accelerate research and early development through laboratory automation, data management, AI and digital research.  

In Episode 11, host Tom Lehmann and guest Julie Huxley-Jones, GSK, discuss the mindset of scientific curiosity, innovation and collaboration and its role on the impact of digital in scientific discovery. They talk about the unique journey of digital in discovery research and how it’s increasing productivity and innovation.

Savyon Amit talks with Tom Lehman about AstraZeneca's aligned understanding of Digital Health and the importance of articulating the value of digital from an organizational standpoint as well as value to the broader healthcare ecosystem.

Tom Lehmann talks with Stephen Davies, VP, Eisai Enterprise Information Technology about Eisai’s human health care philosophy. It’s guiding innovation, shaping digital transformation and encouraging a holistic health care view by leveraging technology beyond traditional therapeutics.

In this episode Venkat Sethuraman, SVP Global Biometrics and Data Science, Bristol-Myers Squibb talks with Tom Lehmann about the critical role of data, design and digital in the future vision for R&D.

Host Tom Lehmann talks with Craig Lipset, a long-time advocate and inspiring innovator in the clinical research and medicine development community. Drawing on his role as co-convenor of the Decentralized Trials and Research Alliance (DTRA), a collaboration of over 120 member organizations, Craig discusses DTRA’s ambitions and priorities for bringing greater accessibility to clinical trials and making decentralized clinical research methods the standard for the industry.

Tom Lehmann talks with Frances Taheri, Accenture Ventures Digital Health Lead, about the need for companies to enable their ecosystems to collaborate freely without compromising data security and privacy in the conclusion of our Life Sciences Tech Trends series.

Tom Lehmann talks again with David Hole about the “bring your own environment” (BYOE) model that will drive the industry’s technology agenda in terms of connectivity, collaboration and the tools that enable them in part four of our Life Sciences Tech Trends series.

Tom Lehmann talks with David Hole, Accenture Life Sciences Talent and Organization Lead, about making technology accessible to all to put powerful capabilities in the hands of people across functions in part three of our Life Sciences Tech Trends series.

Tom Lehmann talks with Andy Greenberg, Accenture North America Digital Health Lead, about the therapeutic potential of massive, intelligent, digital twins in part two of our Life Sciences Tech Trends series.

Host Tom Lehmann begins this special series centered on the 2021 Life Sciences Technology Vision with Shalu Chadha, Accenture Life Sciences Technology Lead, about architecting a better future with technology stacks that are fluid across the ecosystem.